Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy
Cancer Medicine · 2026
DOI: 10.1002/cam4.72146 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2026. Verfasst von Joseph Carmicheal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms, Radiation Tolerance, Radiation-Sensitizing Agents. Die Arbeit nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Radiation therapy (RT) is a mainstay of treatment for a myriad of cancers, often utilized for tumors that are unable to be resected, as well as an adjunct to surgery and chemotherapy. Unfortunately, many cancers are resistant to RT‐induced damage and subsequent cell death. This has spurred the pursuit of novel radiation sensitizers that could potentiate the effects of this widely used and important treatment modality. Since its discovery as a regulated cell death mechanism in 2012, ferroptosis has been studied for its connection to cancer and other known oxidative pathways. With this, the interplay between RT and ferroptosis in cancer has recently begun to be explored. Radiation increases reactive oxygen species (ROS), facilitates lipid peroxidation, and releases free ferrous iron, all of which directly impact the ferroptotic pathway. In conjunction, RT has been shown to induce the expression of ferroptosis‐related molecules (e.g., SLC7A11, GPX4) through the P62‐KEAP1‐NRF2 pathway, thereby preventing cell death via ferroptosis. The use of ferroptosis inducers (FINs) to block these antioxidant mechanisms is a promising area of study as pharmacological radiosensitizers to improve the efficacy of RT and patient outcomes. In this comprehensive narrative review, the molecular connections between ferroptosis, cancer, and radiation will be discussed, the preponderance of existing literature investigating the potential of FINs as radiosensitizers will be presented, and possible areas of future study will be offered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- University of Maryland, Baltimore County, Baltimore, Maryland, USA.
- Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Joseph Carmicheal, Heidi Vieira
Zitieren
APA
Carmicheal, J., Fritson, C. M., Seas, A., Vieira, H., & Batra, S. K. (2026). Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy. Cancer Medicine. https://doi.org/10.1002/cam4.72146
Vancouver
Carmicheal J, Fritson CM, Seas A, Vieira H, Batra SK. Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy. Cancer Medicine. 2026. doi:10.1002/cam4.72146
BibTeX
@article{Carmicheal2026,
author = {Carmicheal, Joseph and Fritson, Caden M and Seas, Alexandra and Vieira, Heidi and Batra, Surinder K},
title = {Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72146}
}
EUVIMED